Reading Outcomes in Children With Vestibular Loss
Father Flanagan's Boys' Home · NCT05414903
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7–18 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- June 6, 2022
- Record last updated
- December 23, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Vestibular loss can co-occur with hearing loss causing dual sensory deficits. This project examines vestibular loss as a contributing factor to reading difficulties for children with hearing loss, where previously only the effects of hearing loss and subsequent language difficulties have been considered. These results are expected to influence the identification and habilitation of vestibular loss in children with hearing loss.
Being studied: Dynamic Visual Acuity; Reading Outcomes; Static Visual Acuity
Conditions: Vestibular Disorder; Hearing Loss, Sensorineural
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Children will be required to have nonverbal problem-solving/intelligence scores within 1.5 SD of the mean (mean = 100, SD = 15, 1.5 SD of mean = 77 - 123).
- Children with normal hearing must have thresholds ≤20 dB HL from 0.25 to 8 kHz.
- Children with hearing loss must have pure-tone averages > 65 dB HL.
Exclusion Criteria
- Fail a vision screen at 20/30
- Have autism, blindness, or other optic disorders, cerebral palsy, significant neurologic involvement, uncorrectable vision problems, and intellectual disability.
- Children with nonverbal problem-solving/intelligence scores > 123 or \< 77 will be excluded.
- Each participant's current medications will be reviewed. Children taking medications known to result in oculomotor slowing will be excluded (i.e., anti-depressants, vestibular suppressants, sedatives, etc).
Recruiting US locations
Boys Town National Research Hospital
Omaha, NE 68131
Site contact: Kristen L Janky, PhD · 15313556535 · kristen.janky@boystown.org
Study contacts (from the official record)
- Kristen L Janky, PhD · 15313556535 · kristen.janky@boystown.org
- Jessie N Patterson, PhD · 15313556333 · jessie.patterson@boystown.org
Similar studies in Nebraska
All healthy volunteers studies in Nebraska →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Grand Island, NE + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Lincoln, NE + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Lincoln, NE + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Merck Sharp & Dohme LLC
- Location
- Lincoln, NE + 5 other US sites
- Eligibility basics
- Ages 12–30